APA

Vourvahis M., Gleave M., Nedderman A. N. R., Hyland R., Gardner I., Howard M., Kempshall S., Collins C. & LaBadie R. (20100917). Excretion and metabolism of lersivirine (5-{[3,5-diethyl-1-(2-hydroxyethyl)(3,5-14C2)-1H-pyrazol-4-yl]oxy}benzene-1,3-dicarbonitrile), a next-generation non-nucleoside reverse transcriptase inhibitor, after administration of [14C]Lersivirine to healthy volunteers. : Drug metabolism and disposition: the biological fate of chemicals.

Chicago

Vourvahis Manoli, Gleave Michelle, Nedderman Angus N R, Hyland Ruth, Gardner Iain, Howard Martin, Kempshall Sarah, Collins Claire and LaBadie Robert. 20100917. Excretion and metabolism of lersivirine (5-{[3,5-diethyl-1-(2-hydroxyethyl)(3,5-14C2)-1H-pyrazol-4-yl]oxy}benzene-1,3-dicarbonitrile), a next-generation non-nucleoside reverse transcriptase inhibitor, after administration of [14C]Lersivirine to healthy volunteers. : Drug metabolism and disposition: the biological fate of chemicals.

Harvard

Vourvahis M., Gleave M., Nedderman A. N. R., Hyland R., Gardner I., Howard M., Kempshall S., Collins C. and LaBadie R. (20100917). Excretion and metabolism of lersivirine (5-{[3,5-diethyl-1-(2-hydroxyethyl)(3,5-14C2)-1H-pyrazol-4-yl]oxy}benzene-1,3-dicarbonitrile), a next-generation non-nucleoside reverse transcriptase inhibitor, after administration of [14C]Lersivirine to healthy volunteers. : Drug metabolism and disposition: the biological fate of chemicals.

MLA

Vourvahis Manoli, Gleave Michelle, Nedderman Angus N R, Hyland Ruth, Gardner Iain, Howard Martin, Kempshall Sarah, Collins Claire and LaBadie Robert. Excretion and metabolism of lersivirine (5-{[3,5-diethyl-1-(2-hydroxyethyl)(3,5-14C2)-1H-pyrazol-4-yl]oxy}benzene-1,3-dicarbonitrile), a next-generation non-nucleoside reverse transcriptase inhibitor, after administration of [14C]Lersivirine to healthy volunteers. : Drug metabolism and disposition: the biological fate of chemicals. 20100917.